Accumulation of periodic‐acid Schiff granules is increased in the presence of humanized amyloid beta. (1st February 2022)
- Record Type:
- Journal Article
- Title:
- Accumulation of periodic‐acid Schiff granules is increased in the presence of humanized amyloid beta. (1st February 2022)
- Main Title:
- Accumulation of periodic‐acid Schiff granules is increased in the presence of humanized amyloid beta
- Authors:
- Forner, Stefania
Javonillo, Dominic I
Tran, Kristine M
Phan, Jimmy
Da Cunha, Celia
Baglietto‐Vargas, David
Kawauchi, Shimako
Tenner, Andrea J
LaFerla, Frank
MacGregor, Grant R
Green, Kim N - Abstract:
- Abstract: Background: Most Alzheimer's disease (AD) cases are sporadic and late‐onset, yet nearly all existing mouse AD models harbor pathogenic mutations, rendering them better representations of familial autosomal‐dominant forms of the disease. As a foundational step to model late‐onset AD (LOAD), we generated and analyzed knock‐in mice that express wildtype human amyloid beta (hAβ‐KI) under control of the mouse App locus in exon 14 flanked by loxP sites (FL). Method: Using a conformation‐specific OC protofibril antibody, we performed immunofluorescence stains on coronal brain slices and quantified the appearance of Periodic Acid‐Shiff (PAS) granules using confocal microscopy. To correlate the appearance of PAS granules with hAβ expression, we crossed hAβ‐KI‐FL mice with UBC‐Cre ERT2 mice to enable Tamoxifen‐inducible cre recombinase‐mediated inactivation of hAβ expression. Finally, we generated hAβ‐KI; PS1 M146V mice to investigate whether co‐expression of familial‐linked AD mutations affect the hAβ‐induced presence of PAS granules. Result: Changing 3 amino acids in the mouse Aβ sequence to its wild‐type human counterpart produced age‐dependent accumulation of PAS granules in the hippocampus of hAβ‐KI mice by 10 months of age. Additionally, we observed impairments in cognition and synaptic plasticity in hAβ‐KI mice. Remarkably, ablating hAβ expression using inducible cre reduced the formation of PAS granules and rescues cognition. Co‐expression of familial‐linked ADAbstract: Background: Most Alzheimer's disease (AD) cases are sporadic and late‐onset, yet nearly all existing mouse AD models harbor pathogenic mutations, rendering them better representations of familial autosomal‐dominant forms of the disease. As a foundational step to model late‐onset AD (LOAD), we generated and analyzed knock‐in mice that express wildtype human amyloid beta (hAβ‐KI) under control of the mouse App locus in exon 14 flanked by loxP sites (FL). Method: Using a conformation‐specific OC protofibril antibody, we performed immunofluorescence stains on coronal brain slices and quantified the appearance of Periodic Acid‐Shiff (PAS) granules using confocal microscopy. To correlate the appearance of PAS granules with hAβ expression, we crossed hAβ‐KI‐FL mice with UBC‐Cre ERT2 mice to enable Tamoxifen‐inducible cre recombinase‐mediated inactivation of hAβ expression. Finally, we generated hAβ‐KI; PS1 M146V mice to investigate whether co‐expression of familial‐linked AD mutations affect the hAβ‐induced presence of PAS granules. Result: Changing 3 amino acids in the mouse Aβ sequence to its wild‐type human counterpart produced age‐dependent accumulation of PAS granules in the hippocampus of hAβ‐KI mice by 10 months of age. Additionally, we observed impairments in cognition and synaptic plasticity in hAβ‐KI mice. Remarkably, ablating hAβ expression using inducible cre reduced the formation of PAS granules and rescues cognition. Co‐expression of familial‐linked AD mutations with hAβ exacerbated the accumulation of PAS granules compared to homozygous hAβ‐KI and WT mice. Conclusion: Substituting mouse Aβ with the wild‐type human isoform produces significant accumulation of PAS granules and impairments in cognition and synaptic plasticity, highlighting its usefulness in investigating risk factors of LOAD. … (more)
- Is Part Of:
- Alzheimer's & dementia. Volume 17(2021)Supplement 3
- Journal:
- Alzheimer's & dementia
- Issue:
- Volume 17(2021)Supplement 3
- Issue Display:
- Volume 17, Issue 3 (2021)
- Year:
- 2021
- Volume:
- 17
- Issue:
- 3
- Issue Sort Value:
- 2021-0017-0003-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2022-02-01
- Subjects:
- Alzheimer's disease -- Periodicals
Alzheimer Disease -- Periodicals
Dementia -- Periodicals
Démence
Maladie d'Alzheimer
Périodique électronique (Descripteur de forme)
Ressource Internet (Descripteur de forme)
616.83 - Journal URLs:
- http://www.sciencedirect.com/science/journal/15525260 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1002/alz.055658 ↗
- Languages:
- English
- ISSNs:
- 1552-5260
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 0806.255333
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25825.xml